Chris Garabedian discusses his company Xontogeny, a biotech aggregator which supports the accelerated development of life science technologies in the pursuit of helping patients with serious diseases.
Xontogeny is a biotech aggregator with a differentiated business model to support the accelerated development of life science technologies in the pursuit of helping patients with serious diseases. Xontogeny partners with entrepreneurs, providing the leadership and operating experience needed to increase the probability of success with early drug and technology development.
Xontogeny focuses on supporting the entrepreneur’s pursuit and optimizing the development pathway with an exceptionally talented and experienced operational team. With our team’s track record of success, entrepreneurs of affiliated companies will gain the support and guidance they need while remaining lean, virtual, and without the financial burden of supporting a full-time team.
